Cargando…

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia

BACKGROUND AND AIMS: Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can improve the cardiovascular prognosis. We evaluated the long-term cardiovascular risk of HeFH using the French REgistry of Familial hypERCHOLesterolemia (REFERCHOL). METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrières, Jean, Farnier, Michel, Bruckert, Eric, Vimont, Alexandre, Durlach, Vincent, Ferrari, Emile, Gallo, Antonio, Boccara, Franck, Ferrières, Dorota, Béliard, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833221/ https://www.ncbi.nlm.nih.gov/pubmed/36643794 http://dx.doi.org/10.1016/j.athplu.2022.08.001

Ejemplares similares

Prevalence and management of hypercholesterolemia in France, the Esteban observational study
por: Blacher, Jacques, et al.
Publicado: (2020)

Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
por: Ferrières, Jean, et al.
Publicado: (2023)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists
por: Ferrières, Jean, et al.
Publicado: (2021)

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
por: Gallo, Antonio, et al.
Publicado: (2021)

Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis
por: Matta, Anthony, et al.
Publicado: (2021)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia
por: Ekrami, Mahdis, et al.
Publicado: (2018)

Contemporary trends in anaphylaxis burden and healthcare utilisation in Western Australia: A linked data study
por: Stiles, Samantha L., et al.
Publicado: (2023)

Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes
por: Fonzar, Waleria T., et al.
Publicado: (2022)

Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
por: Johansen, Anja K., et al.
Publicado: (2023)

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020)

Role of an automated screening tool for familial hypercholesterolemia in patients with premature coronary artery disease
por: Jokiniitty, Antti, et al.
Publicado: (2022)

Subclinical atherosclerosis determined by coronary artery calcium deposition in patients with clinical familial hypercholesterolemia
por: Borg, Sanna á, et al.
Publicado: (2022)

Increased extracellular vesicles (EVs) related to T cell-mediated inflammation and vascular function in familial hypercholesterolemia
por: Nielsen, Morten Hjuler, et al.
Publicado: (2023)

Lipids, lipoproteins and prevalence of familial hypercholesterolemia in the Faroe Islands – Results from a nationwide laboratory database
por: Borg, Sanna á, et al.
Publicado: (2022)

Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey
por: Yao, Hermann, et al.
Publicado: (2021)

Contemporary kidney transplantation has a limited impact on bone microarchitecture
por: Meng, Catarina, et al.
Publicado: (2022)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
por: Kastelein, John J. P., et al.
Publicado: (2014)

A heterozygous N-terminal truncation mutation of NFKBIA results in an impaired NF-κB dependent inflammatory response
por: Wen, Wen, et al.
Publicado: (2021)

A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients
por: Li, Fangyuan, et al.
Publicado: (2022)

Outcomes of recurrent laryngeal nerve injury following congenital heart surgery: A contemporary experience
por: Alfares, Fahad A., et al.
Publicado: (2016)

Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database
por: Vimont, Alexandre, et al.
Publicado: (2023)

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
por: McGowan, Mary P., et al.
Publicado: (2019)

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
por: Vuorio, Alpo, et al.
Publicado: (2018)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

The Association of Contemporary Screen Behaviours with Physical Activity, Sedentary Behaviour and Sleep in Adolescents: a Cross-sectional Analysis of the Millennium Cohort Study
por: Kontostoli, Elli, et al.
Publicado: (2022)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

The US population-level burden of cow's milk allergy
por: Warren, Christopher M., et al.
Publicado: (2022)

Economic burden of severe asthma treatment: A real-life study()
por: López-Tiro, Jesús, et al.
Publicado: (2022)

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
por: Ershova, Alexandra I., et al.
Publicado: (2016)

The disease burden and quality of life of chronic cough patients in South Korea and Taiwan()
por: Yu, Chong-Jen, et al.
Publicado: (2022)

Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer
por: Alikhani, Mehdi, et al.
Publicado: (2021)

Cardiovascular risk factors burden in Saudi Arabia: The Africa Middle East Cardiovascular Epidemiological (ACE) study
por: Ahmed, Amjad M., et al.
Publicado: (2017)

Childhood sexual abuse history amplifies the link between disease burden and inflammation among older adults with HIV
por: Derry, Heather M., et al.
Publicado: (2021)

Assessing the national burden of allergic asthma by web-search data, pollen counts, and drug prescriptions in Germany and Sweden()
por: Sitaru, Sebastian, et al.
Publicado: (2023)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2020)

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
por: Sonnett, Travis, et al.
Publicado: (2010)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6cg2gqtu78b6bacnf6pu29i82u